Literature DB >> 3923914

Structure and functions of Pseudomonas aeruginosa lipopolysaccharide.

A M Kropinski, B Jewell, J Kuzio, F Milazzo, D Berry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3923914     DOI： 10.1159/000410472

Source DB:  PubMed          Journal:  Antibiot Chemother (1971)        ISSN： 0066-4758


× No keyword cloud information.
  17 in total

1.  Common antigen lipopolysaccharide from Pseudomonas aeruginosa AK1401 as a receptor for bacteriophage A7.

Authors:  M Rivera; T R Chivers; J S Lam; E J McGroarty
Journal:  J Bacteriol       Date:  1992-04       Impact factor: 3.490

2.  Immunochemical analysis of lipopolysaccharides from free-living and endosymbiotic forms of Rhizobium leguminosarum.

Authors:  S S Sindhu; N J Brewin; E L Kannenberg
Journal:  J Bacteriol       Date:  1990-04       Impact factor: 3.490

3.  Induction of inflammatory mediators (histamine and leukotrienes) from rat peritoneal mast cells and human granulocytes by Pseudomonas aeruginosa strains from burn patients.

Authors:  U Bergmann; J Scheffer; M Köller; W Schönfeld; G Erbs; F E Müller; W König
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

4.  Occurrence of a common lipopolysaccharide antigen in standard and clinical strains of Pseudomonas aeruginosa.

Authors:  M Y Lam; E J McGroarty; A M Kropinski; L A MacDonald; S S Pedersen; N Høiby; J S Lam
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

5.  Fatty acid alterations and polymyxin B binding by lipopolysaccharides from Pseudomonas aeruginosa adapted to polymyxin B resistance.

Authors:  R S Conrad; C Galanos
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

6.  Molecular structures that influence the immunomodulatory properties of the lipid A and inner core region oligosaccharides of bacterial lipopolysaccharides.

Authors:  P J Baker; T Hraba; C E Taylor; P W Stashak; M B Fauntleroy; U Zähringer; K Takayama; T R Sievert; X Hronowski; R J Cotter
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

7.  Structural elucidation of the lipopolysaccharide core region of the O-chain-deficient mutant strain A28 from Pseudomonas aeruginosa serotype 06 (International Antigenic Typing Scheme).

Authors:  H Masoud; I Sadovskaya; T de Kievit; E Altman; J C Richards; J S Lam
Journal:  J Bacteriol       Date:  1995-12       Impact factor: 3.490

8.  Enhanced binding of polycationic antibiotics to lipopolysaccharide from an aminoglycoside-supersusceptible, tolA mutant strain of Pseudomonas aeruginosa.

Authors:  M Rivera; R E Hancock; J G Sawyer; A Haug; E J McGroarty
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

9.  Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients.

Authors:  G Kronborg; A Fomsgaard; C Galanos; M A Freudenberg; N Høiby
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

10.  Enhancement of lipopolysaccharide-induced tumor necrosis factor secretion by hyperimmune serum from chronic infected patients.

Authors:  G Kronborg; A Fomsgaard; N Høiby
Journal:  Med Microbiol Immunol       Date:  1993-12       Impact factor: 3.402
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.